Riskpilot← Back to searchSign inGet full accessBvE ApS
APSActiveCVR 37191051Morsøvej 18Activities of holding companies · NACE 6421Est. 2015— employees
Revenue 2024
DKK -4K
-78% vs 2023
EBITDA margin
100.0%
+78% vs 2023
Equity ratio
100.0%
Financial strength
Net profit 2024
DKK 298K
-61% vs 2023
| Revenue | DKK -4K | -78% |
| EBITDA | DKK -4K | +78% |
| Net profit | DKK 298K | -61% |
| Total assets | DKK 2,2M | -3% |
| Equity | DKK 2,2M | +12% |
| Employees | — | — |
Legal name
BvE ApS
CVR number
37191051
Legal form
Anpartsselskab
NACE code
6421 · Activities of holding companies
Founded
30. oktober 2015
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen
Company purpose
Virksomhedens formål er at besidde kapitalandele og anden hermed beslægtet virksomhed efter ledelsens skøn.
Address
Morsøvej 18
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | -0 | -0 | -0 | -10 | -16 | -16 | -4 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 0 | 0 | -0 | -0 | -0 | -10 | -16 | -16 | -4 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | 0 | -0 | -0 | -0 | -10 | -16 | -16 | -4 |
| Net financials | -3 | 115 | 82 | 311 | 621 | -11 | 127 | 781 | 302 |
| Profit before tax | -3 | 115 | 82 | 311 | 621 | -21 | 111 | 764 | 298 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -3 | 115 | 82 | 311 | 621 | -21 | 111 | 764 | 298 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 33 | 51 | 2.044 | 2.045 | 3.510 | 2.180 | 2.037 | 2.212 | 2.156 |
| Equity | -3 | 50 | 132 | 443 | 1.064 | 1.043 | 1.154 | 1.919 | 2.156 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 36 | 1 | 1.912 | 1.602 | 2.445 | 1.137 | 883 | 293 | 0 |
| Total debt | 36 | 1 | 1.912 | 1.602 | 2.445 | 1.137 | 883 | 293 | 0 |
EBITDA margin
-354000.0%
This company
15.8%
Market median
-2240606% vs market
20162024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20162024
Return on equity
13.8%
This company
18.4%
Market median
+25% vs market
20162024
Net profit margin
29819300.0%
This company
8.1%
Market median
+368139406% vs market
20162024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20162024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20162024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2015-10-30 – 2016-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2015 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
BvE ApS 
Global Clinical Research Institute ApSBoard members of BvE ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|